Molecular biology of the aromatic hydrocarbon (dioxin) receptor

doi:10.1016/0165-6147(94)90316-6

Trends in Pharmacological Sciences

Volume 15, Issue 7, July 1994, Pages 226-232

https://doi.org/10.1016/0165-6147(94)90316-6 Get rights and content

Abstract

The aromatic hydrocarbon (AH) (dioxin) receptor was discovered almost 20 years ago and achieved notoriety as the front-line site of action of highly toxic environmental chemicals such as halogenated dioxins and polychlorinated biphenyls. Increasing evidence suggests that the AH receptor plays a key role in proliferation and differentiation of cells exposed to dioxins and, perhaps, to endogenous ligands. Recent cloning of the AH receptor and its indispensable partner, the AH-receptor-nuclear-translocator protein, has opened new opportunities to determine how the AH receptor functions, how it evolved and what its multiple roles might be in normal physiology as well as in toxicology. This review by Allan Okey, David Riddick and Patricia Harper aims to provide a brief history of AH receptor research and gives a timely summary of what is known and what is not known about the structure and function of this fascinating protein.

References (70)

L. Poellinger et al.
Trends Pharmacol. Sci.
(1992)
O. Hankinson
Arch. Biochem. Biophys.
(1993)
A.B. Okey et al.
Toxicol. Lett.
(1994)
G.H. Perdew
Biochem. Biophys. Res. Commun.
(1992)
S.M.F. de Morais et al.
J. Biol. Chem.
(1994)
I. Pongratz et al.
J. Biol. Chem.
(1992)
A.B. Okey
J. Biol. Chem.
(1980)
M.S. Denison et al.
J. Biol. Chem.
(1988)
R.T. Dunn et al.
Biochem. Pharmacol.
(1993)
R.D. Prokipcak et al.
Arch. Biochem. Biophys.
(1988)

R.D. Prokipcak et al.

Biochem. Biophys. Res. Commun.

(1990)

C.J. Elferink et al.

J. Biol. Chem.

(1990)

G.G.F. Mason

J. Biol. Chem.

(1994)

N. Matsushita et al.

J. Biol. Chem.

(1993)

G.H. Perdew

Arch. Biochem. Biophys.

(1991)

S.T. Okino et al.

J. Biol. Chem.

(1992)

J.J. Reiners et al.

Arch. Biochem. Biophys.

(1993)

M.W. Schafer et al.

Arch. Biochem. Biophys.

(1993)

K. Gradin et al.

J. Biol. Chem.

(1993)

A. Lusska et al.

J. Biol. Chem.

(1992)

A.J. Watson et al.

J. Biol. Chem.

(1992)

P.D. Boucher et al.

J. Biol. Chem.

(1993)

T.C. Sloop et al.

Toxicol. Appl. Pharmacol.

(1987)

D.S. Riddick et al.

J. Biol. Chem.

(1994)

M. Merchant et al.

Arch. Biochem. Biophys.

(1992)

T.R. Sutter et al.

Chemosphere

(1992)

L.C. Quattrochi et al.

J. Biol. Chem.

(1994)

L.H. Pottenger et al.

Arch. Biochem. Biophys.

(1991)

T.R. Sutter

J. Biol. Chem.

(1994)

A.B. Okey

Pharmacol. Ther.

(1990)

A.B. Rifkind et al.

Biochem. Biophys. Res. Commun.

(1990)

M. Ema

Biochem. Biophys. Res. Commun.

(1992)

J.V. Schmidt et al.

J. Biol. Chem.

(1993)

P.A. Harper et al.

Arch. Biochem. Biophys.

(1991)

M.S. Denison et al.

Chemosphere

(1986)

Cited by (233)

The effects of P-glycoprotein induction on ivermectin-induced behavioural alterations in zebrafish (Danio rerio) under varying diets
2023, Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology
The neuroprotective effects of inducing the blood-brain barrier ATP-binding cassette protein transporter P-glycoprotein (P-gp) with clotrimazole (CTZ) in both fed and fasted zebrafish (Danio rerio) against the CNS-toxicant ivermectin (IVM, 22,23-dihydro avermectin B1a + 22,23-dihydro avermectin B1b) were examined. Zebrafish were administered 2 μmol/kg IVM intraperitoneally, and various behavioural assays (swimming performance, exploratory behaviour, olfactory responses, motor coordination, and escape responses) were used to measure neurological dysfunction. IVM administration alone caused a decrease in mean swim speed (91 % of controls), maximal speed (71 %), passage rate (81 %), 90° turns (81 %), and response to food stimulus (39 %). IVM exposure also increased the percent time that fish spent immobile (45 % increase over controls) and the percent of lethargic fish (40 % increase). Fish administered 30 μmol/kg of the P-gp inducer CTZ intraperitoneally 3 d prior to IVM exposure exhibited a change in only the % time spent immobile. These data indicate that P-gp induction may be limited in protecting the zebrafish CNS from IVM over baseline. Fasted fish did not differ from fed fish in the effects of IVM on behaviour, and no differences were seen following P-gp induction with CTZ. These results suggest that this chemical defence system is not downregulated when fish are challenged with limited energy availability.
Aryl hydrocarbon receptor: A bridge linking immuno-inflammation and metabolism in atherosclerosis
2023, Biochemical Pharmacology
Cardiovascular disease is the leading cause of death worldwide, and atherosclerosis is a major contributor to this etiology. The ligand-activated transcription factor, known as the aryl hydrocarbon receptor (AhR), plays an essential role in the interactions between genes and the environment. In a number of human diseases, including atherosclerosis, the AhR signaling pathway has recently been shown to be aberrantly expressed and activated. It’s reported that AhR can regulate the immuno-inflammatory response and metabolism pathways in atherosclerosis, potentially serving as a bridge that links these processes. In this review, we highlight the involvement of AhR in atherosclerosis. From the literature, we conclude that AhR is a potential target for controlling atherosclerosis through precise interventions.
Aromatic hydrocarbon receptors in mitochondrial biogenesis and function
2021, Mitochondrion
Citation Excerpt :
Like the adaptive immune system, which is capable of recognizing and responding to a wide variety of antigens, chemical surveillance systems have evolved as mechanisms for recognizing a broad range of chemical structures and initiating appropriate responses (Hahn, 2002). Since its discovery in 1976 (Landers and Bunce, 1991), the biochemical, physicochemical, and recently, molecular properties of the AhR in rodents (and to a lesser extent, in humans) have been extensively characterized (Swanson and Bradfield, 1993; Hankinson, 1995; Jones et al., 1985; Nebert et al., 1993; Okey et al., 1994; Okey et al., 1994; Rowlands and Gustafsson, 1997; Schmidt and Bradfield, 1996; Higginbotham et al., 1968). Initially, scientists were intrigued by the extreme toxicity of chlorinated dibenzo-p-dioxins such as TCDD in animals (Schwetz et al., 1973; Poland and Glover, 1973).
Mitochondria are ubiquitous membrane-bound organelles that not only play a key role in maintaining cellular energy homeostasis and metabolism but also in signaling and apoptosis. Aryl hydrocarbons receptors (AhRs) are ligand-activated transcription factors that recognize a wide variety of xenobiotics, including polyaromatic hydrocarbons and dioxins, and activate diverse detoxification pathways. These receptors are also activated by natural dietary compounds and endogenous metabolites. In addition, AhRs can modulate the expression of a diverse array of genes related to mitochondrial biogenesis and function. The aim of the present review is to analyze scientific data available on the AhR signaling pathway and its interaction with the intracellular signaling pathways involved in mitochondrial functions, especially those related to cell cycle progression and apoptosis. Various evidence have reported the crosstalk between the AhR signaling pathway and the nuclear factor κB (NF-κB), tyrosine kinase receptor signaling and mitogen-activated protein kinases (MAPKs). The AhR signaling pathway seems to promote cell cycle progression in the absence of exogenous ligands, whereas the presence of exogenous ligands induces cell cycle arrest. However, its effects on apoptosis are controversial since activation or overexpression of AhR has been observed to induce or inhibit apoptosis depending on the cell type. Regarding the mitochondria, although activation by endogenous ligands is related to mitochondrial dysfunction, the effects of endogenous ligands are not well understood but point towards antiapoptotic effects and inducers of mitochondrial biogenesis.
The aryl hydrocarbon receptor: An environmental effector in the pathogenesis of fibrosis
2020, Pharmacological Research
Citation Excerpt :
The aryl hydrocarbon receptor (AhR), also known as the dioxin receptor, is a highly conserved transcription factor that is activated by environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) [1], as well as small molecules provided by dietary, plant, or microbial metabolites [2]. AhR is widely expressed in various cell subsets and can involve in a variety of biological processes [2,3]. Although the function of AhR is not fully understood, evidence has shown that AhR regulates the cell cycle, tumorigenesis, the immune balance, and skin functions [4–6].
The aryl hydrocarbon receptor (AhR) is a highly conserved transcription factor that can be activated by small molecules provided by dietary, plant, or microbial metabolites, and environmental pollutants. AhR is expressed in many cell types and engages in crosstalk with other signaling pathways, and therefore provides a molecular pathway that integrates environmental cues and metabolic processes. Fibrosis, which is defined as an aberrant extracellular matrix formation, is a reparative process in the terminal stage of chronic diseases. Both environmental and internal factors have been shown to participate in the pathogenesis of fibrosis; however, the underlying mechanisms still remain elusive. In this review, the potential role of AhR in the process of fibrosis, as well as potential opportunities and challenges in the development of AhR targeting therapeutics, are summarized.
The Role of Biotransformation in Developmental Toxicity
2018, Comprehensive Toxicology: Third Edition
Biotransformation within both the mother and her developing embryo and fetus can play a variety of important roles in determining developmental toxicity or teratogenicity. Although the term “biotransformation” is typically associated with the metabolism of drugs and endogenous substrates, we have expanded this term to include reactions involved particularly in the formation and detoxification of reactive oxygen species, and the repair of oxidatively damaged DNA. The mother’s metabolism of a drug or environmental chemical (xenobiotic) can determine its elimination, thereby regulating the maternal plasma concentration of the xenobiotic, which in turn determines how much is available for transfer to the developing embryo or fetus. Once in the embryo or fetus, conceptal “bioactivating” pathways may convert a relatively nontoxic xenobiotic to a highly reactive and potentially toxic intermediary metabolite, such as an electrophilic or free radical intermediate, which can covalently (irreversibly) bind to or oxidatively damage embryonic cellular macromolecules such as DNA, RNA, proteins, and lipids, and/or directly alter cellular signal transduction. Oxidative damage and altered signal transduction are also caused by reactive oxygen species (ROS), which can be initiated by a drug-free radical or by drug-induced increases in endogenous pathways of ROS formation, such as ROS-producing NADPH oxidases (NOX). A teratogenic outcome will be dependent in part upon the mitigating protective effects of embryonic biotransforming pathways that detoxify either the xenobiotic reactive intermediate or the ROS initiated by some xenobiotics. A subsequent level of protection is afforded by embryonic pathways for the repair or removal of damaged cellular macromolecules. The regulatory effects of maternal xenobiotic metabolism and the balance among embryonic pathways of bioactivation and ROS formation, reactive intermediate and ROS detoxification, and repair of cellular macromolecules together determine the adverse developmental outcomes of xenobiotic exposure during pregnancy. Individual maternal and embryonic differences in these pathways of biotransformation, due to either genetic or environmental factors, can therefore constitute important determinants of risk.
A role for benzo[a]pyrene and Slug in invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis: A potential molecular link between smoking and radiographic progression
2013, Joint Bone Spine
To investigate the effects of benzo[a]pyrene (B[a]P), a major toxic component of cigarette smoke, on the expression of Slug and to determine the effect of B[a]P/Slug on the invasive properties of rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS).
The expression of Slug was measured by real-time PCR following the stimulation of FLS with different concentrations of B[a]P or EGF. The phosphorylation of the key enzymes in the signaling pathway was analyzed by western blots. Inhibitors of PI3K/Akt/mTOR pathway were used to confirm the critical pathway for Slug expression. An in vitro cell invasion assay was performed using RA FLS treated with Slug cDNA, Slug small interference RNA, or control.
Slug expression increased significantly following treatment with B[a]P or EGF in a dose-dependent manner. The stimulation of FLS with B[a]P or EGF induced the phosphorylation of Akt kinase, but not in ERK, JNK and p38. The Slug mRNA expression induced by B[a]P and EGF decreased significantly following the treatment with PI3K/Akt/mTOR inhibitors. Slug overexpression using Slug cDNA upregulated the invasive function of FLS, and Slug depletion using siRNA showed the opposite effect compared with the control. In addition, the stimulation with B[a]P increased the invasive function of the control siRNA-treated FLS but not in the Slug siRNA-treated FLS.
Our data showed that B[a]P regulates the invasive properties of RA FLS through Slug expression. This mechanism may provide a novel molecular link underlying the association between smoking and increased radiographic progression in RA.

View all citing articles on Scopus

View full text

Trends in Pharmacological Sciences

ReviewMolecular biology of the aromatic hydrocarbon (dioxin) receptor

Abstract

Trends Pharmacol. Sci.

Arch. Biochem. Biophys.

Toxicol. Lett.

Biochem. Biophys. Res. Commun.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Biochem. Pharmacol.

Arch. Biochem. Biophys.

Biochem. Biophys. Res. Commun.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Arch. Biochem. Biophys.

J. Biol. Chem.

Arch. Biochem. Biophys.

Arch. Biochem. Biophys.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Toxicol. Appl. Pharmacol.

J. Biol. Chem.

Arch. Biochem. Biophys.

Chemosphere

J. Biol. Chem.

Arch. Biochem. Biophys.

J. Biol. Chem.

Pharmacol. Ther.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

J. Biol. Chem.

Arch. Biochem. Biophys.

Chemosphere

Review
Molecular biology of the aromatic hydrocarbon (dioxin) receptor